Investigators stressed that the method is simple, doesn’t require ultrasound, and can be done with existing cath lab ...
In this analysis, 214 U.S. patients received the recently approved RYBREVANT FASPRO plus LAZCLUZE regimen with prophylactic strategies to reduce the risk of blood clots with oral anticoagulation and ...
Is testosterone screening in the military trying to create “High-T” warfighters or treat a hormone deficiency that can affect ...
Serena Williams knows what it means to fight through pain when the world is watching. But one of her toughest battles came ...
Updated AHA and ASA guidelines emphasize interprofessional care and inpatient rehabilitation facilities for poststroke recovery.
Enhertu Demonstrated a Median 14.3 Month Progression-Free Survival as First-Line Therapy in Patients with HER2 Mutant ...
Early, consistently managed treatment can have a decisive impact on the course of rheumatoid arthritis and prevent permanent ...
Positive results from the DESTINY-Lung04 Phase III trial showed AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically ...
Terminology shifts to “decompensated heart failure,” introducing an initial–stabilization–pre/postdischarge framework and ...
A more than decade-long randomized trial suggests that implantable cardioverter-defibrillators may benefit some patients who have heart scarring and only mild-to-moderate loss of heart function, a ...
Kim of the Department of Neurology at Korea University Guro Hospital and his research team successfully conducted a ...
Anaemia affected 52% of patients with paediatric IBD at diagnosis and remained associated with disease activity over five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results